findmyKOL

Michael Rosove, MD

Basic profile

UCLA Health

ORCIDNPI
RegionLos Angeles, CA · WestSpecialtyHematology / OncologyFocusOncology
Last active 1985findmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publicationSee ScholarshipOnline presenceNot yet checkedPaymentsNone reportedNIH funding1985–1985Why? →

Michael Rosove is an Oncology physician affiliated with UCLA Health. OpenAlex indexes 76 publications with 2,779 citations (h-index 20).

Overview

Scholarship

indexed output and impact (OpenAlex)
76publications

Distinct works indexed by OpenAlex, matched via ORCID.

2,779citations

Total citations across indexed works.

20h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
1NIH grants · 1985–1985

Federally funded research awards.

View funding

Medicare prescribing footprint (2022)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Anti-infectives

    71.7%
    Human Immunoglobulin G71.7%
    Immune globulin100%
    Part B, office-administered13 patients
  • Metabolism & gastrointestinal

    12.1%
    Serotonin-3 Receptor Antagonist11.6%
    Ondansetron hydrochloride66%Palonosetron hcl35%
    Part B, office-administered15 patients
    Corticosteroid0.6%
    Prednisone100%
    Part D<11 patients
  • Sensory organs

    9.8%
    Corticosteroid9.8%
    Dexamethasone sodium phosphate100%
    Part B, office-administered17 patients
Where care is delivered (Part B)0.6% facility · 99.4% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

1 NIH research award on record, funded 19851985 per NIH RePORTER. The latest:

Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”